Assistant Professor of Oncology, Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA
Institute of Cancer Therapeutics University of Bradford, UK.
Associate Professor,Faculty of Pharmacy,Department Of Pharmacology and Therapeutics,Kuwait University.
Harvard Medical School Chief, Division of Translational Therapeutics, Department of Medicine, Director of Translational Therapeutics, Cancer Research Institute, United States.
Formulation Scientist at Insys Therapeutics
Senior Research Associate, Department of Therapeutic Endocrinology, Endocrinology Research Center, Moscow, Russia
Senior Scientist/Pre-Clinical Manager, Repros Therapeutics, The Woodlands, TX
Diagnostic and Therapeutic Technologies Department, School of Health Sciences - Polytechnic Institute of Bragança, Portugal
Ph.D. in Pharmaceutical Sciences, Formulation Scientist, Insys Therapeutics, University of Nebraska Medical Center, USA
Department of Clinical and Experimental Therapeutics, University of Georgia, Augusta, USA
Postdoctoral research Fellow in the Department of Neurology and Neurotherapeutics at University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Assistant Professor in the Department of Molecular Pharmacology and Therapeutics of Loyola University Chicago, USA.
Author(s): Xiang Zhang, Wanqi Xu and Linfang Huang
Author(s): Maria J Benito
Author(s): Chellappan Biju V, Shidhi PR, Veena S Rajan, Anoop PK and Achuthsankar S Nair
Bruton’s Tyrosine Kinase (Btk) Inhibitor Tirabrutinib Prevents the Development of Murine Lupus
Author(s): Yuko Ariza, Masayuki Murata, Yoshiko Ueda and Toshio Yoshizawa*
Author(s): Tijjani MB, Ngulde SI, Lewis A, Lamidi IY and Barkindo AA
Author(s): Joseph A. Di Como
Author(s): Araujo AJS, Jesus-Lima JCR, Otoch JP and Pessoa AFM
Author(s): Okafor PN, Nwankpa P, Ekweogu CN, Etteh CC and Ugwueznmba PC
Author(s): Raj Kamal, Mohan Natrajan, Vinay K Pathak and Alpana Kumari